Beijing Scitop Bio-tech Co., Ltd. (SHE:300858)
China · Delayed Price · Currency is CNY 23.45
+0.21 (0.90%)
Apr 21, 2026, 3:09 PM CST
Beijing Scitop Bio-tech Revenue
Beijing Scitop Bio-tech had revenue of 104.04M CNY in the quarter ending September 30, 2025, with 28.98% growth. This brings the company's revenue in the last twelve months to 351.47M, up 16.76% year-over-year. In the year 2024, Beijing Scitop Bio-tech had annual revenue of 302.79M with 1.19% growth.
Revenue (ttm)
351.47M
Revenue Growth
+16.76%
P/S Ratio
17.58
Revenue / Employee
1.19M
Employees
295
Market Cap
6.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 302.79M | 3.55M | 1.19% |
| Dec 31, 2023 | 299.24M | -69.92M | -18.94% |
| Jan 1, 2023 | 369.17M | 4.55M | 1.25% |
| Dec 31, 2021 | 364.62M | 25.46M | 7.51% |
| Dec 31, 2020 | 339.16M | 31.06M | 10.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anhui Huaheng Biotechnology | 2.86B |
| Kexing Biopharm | 1.54B |
| Xiangxue Pharmaceutical | 1.47B |
| Nanjing Vazyme Biotech | 1.38B |
| Shenzhen Weiguang Biological Products | 1.14B |
| Wuhan Keqian Biology Co.,Ltd | 949.74M |
| Beijing Konruns Pharmaceutical | 871.31M |
| R&G PharmaStudies | 851.01M |